COVID-19 Vaccine and Long COVID: A Scoping Review

As the COVID-19 pandemic progresses, changing definitions and therapeutics regarding the post-acute sequela of COVID-19, particularly long COVID, have become a subject of great interest and study. The study aims to describe the pathophysiology and discuss different therapeutic agents currently avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Mumtaz, Aqsa, Sheikh, Abdul Ahad Ehsan, Khan, Amin Moazzam, Khalid, Subaina Naeem, Khan, Jehanzaeb, Nasrullah, Adeel, Sagheer, Shazib, Sheikh, Abu Baker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324565/
https://www.ncbi.nlm.nih.gov/pubmed/35888154
http://dx.doi.org/10.3390/life12071066
Descripción
Sumario:As the COVID-19 pandemic progresses, changing definitions and therapeutics regarding the post-acute sequela of COVID-19, particularly long COVID, have become a subject of great interest and study. The study aims to describe the pathophysiology and discuss different therapeutic agents currently available for long COVID. Another objective is to assess comparative efficacy between different types of vaccines on symptoms of long COVID. A preliminary search was conducted using Ovid Medline, Embase, medRxiv, and NIH COVID-19 portfolios. A total of 16 studies were included in our review. Despite some of the data showing variable results, most of the vaccinated patients reported improvement in long COVID symptoms with no significant difference between various types of vaccines. Further trials are needed to better identify the comparative efficacy of vaccines for long COVID and ascertain other therapeutic modalities.

Ejemplares similares